Finding patients earlier

Case Study: Detecting signs of Fabry and Pompe disease in UK clinical data

Volv, supported by Sanofi, and working with Optimum Patient Care, and collaborating with a specialist Consultant Clinician, is performing research…

3 years ago

White Paper: The Path to Rare Disease Clinical Trial Innovation

By Volv Global SA and WODC EU contributors   Executive Summary For decades, the pharmaceutical industry has faced the same…

3 years ago

Paul’s Experience: Narcolepsy and diagnosis – an 8 year odyssey

By Christopher Rudolf, Volv Global Introduction Rare Disease Day highlights the voices, stories, and experiences of millions of people living…

5 years ago